Your browser doesn't support javascript.
loading
TERT rs2736100 A>C SNP and JAK2 46/1 haplotype significantly contribute to the occurrence of JAK2 V617F and CALR mutated myeloproliferative neoplasms - a multicentric study on 529 patients.
Trifa, Adrian P; Banescu, Claudia; Tevet, Mihaela; Bojan, Anca; Dima, Delia; Urian, Laura; Török-Vistai, Tünde; Popov, Viola M; Zdrenghea, Mihnea; Petrov, Ljubomir; Vasilache, Anca; Murat, Meilin; Georgescu, Daniela; Popescu, Mihaela; Patrinoiu, Oana; Balea, Marius; Costache, Roxana; Coleș, Elena; Șaguna, Carmen; Berbec, Nicoleta; Vladareanu, Ana-Maria; Mihaila, Romeo G; Bumbea, Horia; Cucuianu, Andrei; Popp, Radu A.
Afiliação
  • Trifa AP; Department of Medical Genetics, 'Iuliu Hațieganu' University of Medicine and Pharmacy, Cluj-Napoca, Romania.
  • Banescu C; Department of Genetics, 'Ion Chiricuța' Cancer Institute, Cluj-Napoca, Romania.
  • Tevet M; Department of Genetics, University of Medicine and Pharmacy, Tîrgu-Mureș, Romania.
  • Bojan A; Department of Haematology, Colentina Hospital, Bucharest, Romania.
  • Dima D; Department of Haematology, 'Ion Chiricuța' Cancer Institute, Cluj-Napoca, Romania.
  • Urian L; Department of Haematology, 'Iuliu Hațieganu' University of Medicine and Pharmacy, Cluj-Napoca, Romania.
  • Török-Vistai T; Department of Haematology, 'Ion Chiricuța' Cancer Institute, Cluj-Napoca, Romania.
  • Popov VM; Department of Haematology, 'Ion Chiricuța' Cancer Institute, Cluj-Napoca, Romania.
  • Zdrenghea M; Department of Haematology, 'Iuliu Hațieganu' University of Medicine and Pharmacy, Cluj-Napoca, Romania.
  • Petrov L; Department of Haematology, 'Ion Chiricuța' Cancer Institute, Cluj-Napoca, Romania.
  • Vasilache A; Department of Haematology, 'Iuliu Hațieganu' University of Medicine and Pharmacy, Cluj-Napoca, Romania.
  • Murat M; Department of Haematology, Colentina Hospital, Bucharest, Romania.
  • Georgescu D; Department of Haematology, 'Ion Chiricuța' Cancer Institute, Cluj-Napoca, Romania.
  • Popescu M; Department of Haematology, 'Iuliu Hațieganu' University of Medicine and Pharmacy, Cluj-Napoca, Romania.
  • Patrinoiu O; Department of Haematology, 'Ion Chiricuța' Cancer Institute, Cluj-Napoca, Romania.
  • Balea M; Department of Haematology, 'Iuliu Hațieganu' University of Medicine and Pharmacy, Cluj-Napoca, Romania.
  • Costache R; Department of Haematology, 'Ion Chiricuța' Cancer Institute, Cluj-Napoca, Romania.
  • Coleș E; Department of Haematology, Colentina Hospital, Bucharest, Romania.
  • Șaguna C; Department of Haematology, Colentina Hospital, Bucharest, Romania.
  • Berbec N; Department of Haematology, Colentina Hospital, Bucharest, Romania.
  • Vladareanu AM; Department of Haematology, Colentina Hospital, Bucharest, Romania.
  • Mihaila RG; Department of Haematology, Colentina Hospital, Bucharest, Romania.
  • Bumbea H; Department of Medical Genetics, 'Iuliu Hațieganu' University of Medicine and Pharmacy, Cluj-Napoca, Romania.
  • Cucuianu A; Department of Haematology, Colțea Hospital, 'Carol Davila' University of Medicine and Pharmacy, Bucharest, Romania.
  • Popp RA; Department of Haematology, Colțea Hospital, 'Carol Davila' University of Medicine and Pharmacy, Bucharest, Romania.
Br J Haematol ; 174(2): 218-26, 2016 07.
Article em En | MEDLINE | ID: mdl-27061303

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Haplótipos / Telomerase / Calreticulina / Janus Quinase 2 / Transtornos Mieloproliferativos Tipo de estudo: Clinical_trials / Observational_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Haplótipos / Telomerase / Calreticulina / Janus Quinase 2 / Transtornos Mieloproliferativos Tipo de estudo: Clinical_trials / Observational_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article